Inhibition of PTPN21 has antitumor effects in glioma by restraining the EGFR/PI3K/AKT pathway

Protein tyrosine phosphatase non-receptor type 21 (PTPN21) has been recognised as a new tumour-associated protein that is implicated in diverse tumours. However, the correlation between PTPN21 and glioma remains unaddressed. This investigation focused on the relevance of PTPN21 in glioma. The Cancer...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Toxicology and applied pharmacology 2022-09, Vol.451, p.116180-116180, Article 116180
Hauptverfasser:	Li, Xiao-qiang, Liu, Bo-Chuan, Jiang, Xiao-bing, Gao, Wen-wen, Rong, Bo, Wei, Yao, Wang, Feng-lu, Zhao, Hai-kang, Zhang, Liang
Format:	Artikel
Sprache:	eng
Schlagworte:	AKT EGFR Glioma PI3K PTPN21
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!